Exendin-4 exerts its effects through the NGF/p75NTR system in diabetic mouse pancreas

Biochemistry and Cell Biology

Volumn 87, Issue 4, 2009, Pages 641-651

  Gezginci Oktayoglu, Selda ^a   Bolkent, Sehnaz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Exendin 4; Insulin; NGF; p75NTR; Somatostatin

Indexed keywords

APOPTOTIC; BETA CELL; CELL NUCLEAR ANTIGEN; CELLULAR MECHANISMS; CITRATE BUFFER; DIABETIC MICE; EXENDIN-4; FOUR-GROUP; GLUTATHIONE PEROXIDASE; INSULIN SECRETION; MALE MOUSE; NERVE GROWTH FACTOR; NGF; P75 NEUROTROPHIN RECEPTOR; P75NTR; PANCREATIC ISLET; PLASMA GLUCOSE; SECOND GROUP; SOMATOSTATIN; STREPTOZOTOCIN; SUPEROXIDE DISMUTASE ACTIVITIES;

AMINES; ANIMALS; CELL MEMBRANES; GLUCOSE; INDUSTRIAL LABORATORIES; INSULIN; OXYGEN;

SUGAR (SUCROSE);

CATALASE; CELL NUCLEUS ANTIGEN; CITRIC ACID; EXENDIN 4; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; SOMATOSTATIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY MASS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET CELL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED BALB C; PEPTIDES; RECEPTORS, NERVE GROWTH FACTOR; SOMATOSTATIN; STREPTOZOCIN; VENOMS;

ANIMALIA; MUS;

EID: 68049099973     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O09-046     Document Type: Article

References (47)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121-126. doi:10.1016/S0076-6879(84)05016-3. PMID:6727660.
2. Biswas, S.C., Buteau, J., and Greene, L.A. 2008. Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction. Neurochem. Res. 33(9): 1845-1851. doi:10.1007/s11064-008-9646-4. PMID:18351462.
3. NTR and apoptosis: Trk-dependent and Trk-independent effects. Trends Neurosci. 20(7): 287-290. doi:10.1016/S0166-2236(96)01049-1. PMID: 9223218.
4. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865): 813-820. doi:10. 1038/414813a. PMID:11742414. (Pubitemid 34000785)
5. Cabrera-Vásquez, S. 2007. [Neurotrophic control in the development and function of two endocrine organs: the ovary and the pancreas]. Rev. Invest. Clin. 59(3): 219-228. PMID:17910415.
6. Casaccia-Bonnefil, P., Gu, C., Khursigara, G., and Chao, M.V. 1999. p75 neurotrophin receptor as a modulator of survival and death decisions. Microsc. Res. Tech. 45(4-5): 217-224. doi:10. 1002/(SICI)1097-0029(19990515/01)45:4/ 5<217::AID-JEMT5>3.0.CO;2-5. PMID:10383114.
7. Chio, C.C., Chang, Y.H., Hsu, Y.W., Chi, K.H., and Lin, W.W. 2004. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell. Signal. 16(5): 565-575. doi:10.1016/j.cellsig.2003.10.003. PMID: 14751542.
8. Drucker, D.J. 2003. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care, 26(10): 2929-2940. doi:10.2337/diacare.26.10.2929. PMID:14514604.
9. Dugan, L.L., Creedon, D.J., Johnson, E.M., Jr., and Holtzman, D.M. 1997. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 94(8): 4086-4091. doi:10.1073/pnas.94.8.4086. PMID:9108109.
10. Eckersley, L., Ansselin, A.D., and Tomlinson, D.R. 2001. Effects of experimental diabetes on axonal and Schwann cell changes in sciatic nerve isografts. Brain Res. Mol. Brain Res. 92(1-2): 128-137. doi:10.1016/S0169- 328X(01)00163-2. PMID: 11483249.
11. Edwards, C.M., Stanley, S.A., Davis, R., Brynes, A.E., Frost, G.S., Seal, L.J., et al. 2001. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am. J. Physiol. Endocrinol. Metab. 281(1): E155-E161. PMID: 11404233.
12. Egan, J.M., Clocquet, A.R., and Elahi, D. 2002. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J. Clin. Endocrinol. Metab. 87(3): 1282-1290. doi:10.1210/jc.87.3.1282. PMID: 11889200.
13. Egido, E.M., Silvestre, R.A., Hernández, R., and Marco, J. 2004. Exendin-4 dose-dependently stimulates somatostatin and insulin secretion in perfused rat pancreas. Horm. Metab. Res. 36(9): 595-600. doi:10.1055/s-2004- 825921. PMID:15486809.
14. Eissele, R., Bothe-Sandfort, E., Göke, B., Eng, J., Arnold, R., and Koop, H. 1994. Rat gastric somatostatin and gastrin release: interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide. Life Sci. 55(8): 629-634. doi:10.1016/0024-3205(94)00489-7. PMID:7913983. (Pubitemid 24245522)
15. Fernandes, A., King, L.C., Guz, Y., Stein, R., Wright, C.V.E., and Teitelman, G. 1997. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology, 138(4): 1750-1762. doi:10.1210/en.138.4.1750. PMID: 9075740. (Pubitemid 27137131)
16. Göke, R., Fehmann, H.C., Linn, T., Schmidt, H., Krause, M., Eng, J., and Göke, B. 1993. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagonlike peptide 1-(7-36)-amide receptor of insulin-secreting betacells. J. Biol. Chem. 268(26): 19650-19655. PMID:8396143.
17. Greig, N.H., Holloway, H.W., De Ore, K.A., Jani, D., Wang, Y., Zhou, J., et al. 1999. Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia, 42(1): 45-50. doi:10.1007/s001250051111. PMID:10027577. (Pubitemid 29039736)
18. Halliwell, B. 1995. Antioxidant characterization. Methodology and mechanism. Biochem. Pharmacol. 49(10): 1341-1348. doi:10. 1016/0006-2952(95) 00088-H. PMID:7763275.
19. Hamden, K., Boujbiha, M.A., Masmoudi, H., Ayadi, F.M., Jamoussi, K., and Elfeki, A. 2009. Combined vitamins (C and E) and insulin improve oxidative stress and pancreatic and hepatic injury in alloxan diabetic rats. Biomed. Pharmacother. 63(2): 95-99. doi:10.1016/j.biopha.2008.02.001. PMID:18358681.
20. Julien, S., Laine, J., and Morisset, J. 2004. Regulation of rat pancreatic CCKB receptor and somatostatin expression by insulin. Diabetes, 53(6): 1526-1534. doi:10.2337/diabetes.53.6.1526. PMID:15161757. (Pubitemid 38697665)
21. 2+ release and exocytosis in pancreatic beta-cells. J. Biol. Chem. 278(10): 8279-8285. doi:10.1074/jbc. M211682200. PMID: 12496249.
22. Kaplan, D.R., and Miller, F.D. 2000. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10(3): 381-391. doi:10.1016/S0959- 4388(00)00092-1. PMID:10851172.
23. Larietta, M.E., Vital, P., Mendoza-Rodriguez, A., Cerbon, M., and Hiriart, M. 2006. Nerve growth factor increases in pancreatic β cells after streptozotocin-induced damage in rats. Exp. Biol. Med. 231: 396-402.
24. Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P.A., and Drucker, D.J. 2003. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J. Biol. Chem. 278(1): 471-478. doi:10. 1074/jbc.M209423200. PMID:12409292.
25. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1): 265-275. PMID:14907713.
26. Mamidipudi, V., and Wooten, M.W. 2002. Dual role for p75(NTR) signaling in survival and cell death: can intracellular mediators provide an explanation? J. Neurosci. Res. 68(4): 373-384. doi:10.1002/jnr.10244. PMID:11992464.
27. Mattson, M.P., Culmsee, C., Yu, Z., and Camandola, S. 2000. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74(2): 443-456. doi:10.1046/j.1471-4159. 2000.740443.x. PMID:10646495. (Pubitemid 30053716)
28. Murugan, P., and Pari, L. 2007. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. J. Ethnopharmacol. 113(3): 479-486. doi:10.1016/j.jep.2007.07. 004. PMID:17693046. (Pubitemid 47361566)
29. Mylroie, A.A., Collins, H., Umbles, C., and Kyle, J. 1986. Erythrocyte superoxide dimutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicol. Appl. Pharmacol. 82: 512-520. doi:10.1016/0041-008X(86)90286-3. PMID:3952734.
30. Nisticò, G., Ciriolo, M.R., Fiskin, K., Iannone, M., De Martino, A., and Rotilio, G. 1991. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radic. Biol. Med. 12(3): 177-181. doi:10.1016/0891-5849(92) 90024-B.
31. Orskov, C. 1992. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia, 35(8): 701-711. PMID: 1324859.
32. Paglia, D.E., and Valentine, W.N. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70(1): 158-169. PMID:6066618.
33. Perry, T., Lahiri, D.K., Chen, D., Zhou, J., Shaw, K.T., Egan, J.M., and Greig, N.H. 2002. A novel neurotrophic property of glucagon- like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. J. Pharmacol. Exp. Ther. 300(3): 958-966. doi:10.1124/jpet.300.3.958. PMID:11861804.
34. Pierucci, D., Cicconi, S., Bonini, P., Ferrelli, F., Pastore, D., Matteucci, C., et al. 2001. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro. Diabetologia, 44(10): 1281-1295. doi:10.1007/s001250100650. PMID:11692177. (Pubitemid 33010505)
35. Poon, T., Nelson, P., Shen, L., Mihm, M., Taylor, K., Fineman, M., and Kim, D. 2005. Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study. Diabetes Technol. Ther. 7(3): 467-477. doi:10.1089/dia.2005.7.467. PMID:15929678.
36. Raile, K., Klammt, J., Garten, A., Laue, S., Blüher, M., Kralisch, S., et al. 2006. Glucose regulates expression of the nerve growth factor (NGF) receptors TrkA and p75NTR in rat islets and INS-1E beta-cells. Regul. Pept. 135(1-2): 30-38. doi:10.1016/j.regpep.2006.03.004. PMID:16644033.
37. Rao, P.V., Pugazhenthi, S., and Khandelwal, R.L. 1995. The effects of streptozotocin-induced diabetes and insulin supplementation on expression of the glycogen phosphorylase gene in rat liver. J. Biol. Chem. 42: 24955-24960.
38. Robertson, R., Zhou, H., Zhang, T., and Harmon, J.S. 2007. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem. Biophys. 48(2-3): 139-146. doi:10.1007/s12013-007-0026- 5. PMID:17709883.
39. Rosenbaum, T., Vidaltamayo, R., Sánchez-Soto, M.C., Zentella, A., and Hiriart, M. 1998. Pancreatic beta cells synthesize and secrete nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 95(13): 7784-7788. doi:10.1073/pnas.95.13. 7784. PMID:9636228.
40. Roux, P.P., Bhakar, A.L., Kennedy, T.E., and Barker, P.A. 2001. The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276(25): 23097-23104. doi:10.1074/jbc. M011520200. PMID:11312266.
41. Saini, K.S., Thompson, C., Winterford, C.M., Walker, N.I., and Cameron, D.P. 1996. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem. Mol. Biol. Int. 39(6): 1229-1236. PMID:8876977.
42. Sposato, V., Manni, L., Chaldakov, G.N., and Aloe, L. 2007. Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain. Arch. Ital. Biol. 145(2): 87-97. PMID:17639781.
43. Teitelman, G., Guz, Y., Ivkovic, S., and Ehrlich, M. 1998. Islet injury induces neurotrophin expression in pancreatic cells and reactive gliosis of peri-islet Schwann cells. J. Neurobiol. 34(4): 304-318. doi:10.1002/(SICI)1097- 4695(199803)34:4<304::AIDNEU2> 3.0.CO;2-A. PMID:9514521. (Pubitemid 28110406)
44. Tourrel, C., Bailbé, D., Meile, M.J., Kergoat, M., and Portha, B. 2001. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes, 50(7): 1562-1570. doi:10.2337/diabetes.50.7. 1562. PMID: 11423477. (Pubitemid 33639596)
45. Vidaltamayo, R., Mery, C.M., Angeles-Angeles, A., Robles-Diacute;az, G., and Hiriart, M. 2003. Expression of nerve growth factor in human pancreatic beta cells. Growth Factors, 21(3-4): 103-107. doi:10.1080/08977190310001629566. PMID:14708938. (Pubitemid 37541134)
46. Wendel, A. 1981. Glutathione peroxidase. Methods Enzymol. 77: 325-333. doi:10.1016/S0076-6879(81)77046-0. PMID:7329310.
47. Zhou, J., Wang, X., Pineyro, M.A., and Egan, J.M. 1999. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes, 48(12): 2358-2366. doi:10.2337/diabetes.48. 12.2358. PMID:10580424. (Pubitemid 30395427)